Maplight Therapeutics Inc (MPLT)

SG&A Expense Growth

-6.48%

Quarterly · Period ending:

MPLT logo

MPLT SG&A Expense Growth

Latest reported-6.48%
MPLT Quarterly SG&A Growth (QoQ) (0.00% → -6.48%)
High-resolution chart · PNG

MPLT sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Maplight Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-6.484%
-43.1748%
325.8401%
15.3786%
1.6241%
81.9767%
-49.4118%
-6.0557%
10.1166%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.